Digoxin API Manufacturers

Looking for Digoxin API 20830-75-5?

Description:

Here you will find a list of producers, manufacturers and traders of Digoxin. You can sort by certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.

API | Excipient name:

Digoxin 

Synonyms:

Digazolan , Digossina , Digoxin , Digoxina , Digoxine , Digoxinum , Lanadicor  

Cas Number:

20830-75-5 

DrugBank number:

DB00390 

Unique Ingredient Identifier:

73K4184T59

Digoxin is a type of Cardiac glycosides

Cardiac glycosides are a vital subcategory of pharmaceutical active pharmaceutical ingredients (APIs) with significant therapeutic value. These compounds, derived from various plant sources, are known for their potent cardiovascular effects, making them valuable in the treatment of heart-related disorders.

Cardiac glycosides, such as digoxin and digitoxin, exert their pharmacological action by inhibiting the sodium-potassium ATPase pump in cardiac cells. This inhibition leads to an increase in intracellular calcium levels, resulting in enhanced contractility of the heart muscles. By strengthening the heart's pumping action, these glycosides are highly effective in treating conditions like congestive heart failure, atrial fibrillation, and certain types of arrhythmias.

The demand for cardiac glycosides has been driven by the rising prevalence of cardiovascular diseases worldwide. As the population ages and risk factors such as obesity and sedentary lifestyles increase, the need for effective cardiac medications becomes more crucial.

Pharmaceutical companies invest in research and development to improve the synthesis, purification, and formulation processes of cardiac glycosides. This ensures the production of high-quality APIs that comply with stringent regulatory standards. Additionally, advanced extraction techniques and modern analytical methods are employed to ensure the purity, potency, and safety of these APIs.

In conclusion, cardiac glycosides represent a valuable subcategory of pharmaceutical APIs that play a crucial role in the treatment of cardiovascular disorders. With their potent cardiac effects and increasing prevalence of heart-related diseases, the demand for these APIs is expected to remain high. The pharmaceutical industry continues to focus on optimizing the production and quality control processes to ensure the availability of safe and effective cardiac glycoside medications.

Digoxin (Cardiac glycosides), classified under Anti-arrhythmics

Anti-arrhythmics belong to the pharmaceutical API category designed to treat irregular heart rhythms, also known as arrhythmias. These medications work by targeting the electrical signals in the heart, helping to regulate the heart's rhythm and restore it to a normal, steady beat.

Anti-arrhythmics are crucial in managing various types of arrhythmias, such as atrial fibrillation, ventricular tachycardia, and supraventricular tachycardia. These conditions can pose serious risks, including an increased likelihood of stroke or heart failure. Hence, anti-arrhythmics play a vital role in improving patient outcomes and reducing these associated risks.

Pharmaceutical companies develop anti-arrhythmic APIs, which are the active ingredients used to formulate the final medications. These APIs undergo rigorous testing and quality control measures to ensure their safety, efficacy, and consistent performance. They are manufactured in accordance with Good Manufacturing Practices (GMP) guidelines to meet the highest quality standards.

Healthcare professionals prescribe anti-arrhythmics based on the specific arrhythmia type, severity, and individual patient factors. These APIs can be formulated into different dosage forms, including tablets, capsules, or intravenous solutions, depending on the desired route of administration and patient requirements.

It is important to note that anti-arrhythmics are prescription-only medications and should only be used under medical supervision. Patients using these medications must follow their healthcare provider's instructions and regularly monitor their heart rhythm to ensure optimal treatment effectiveness and minimize potential side effects.

In conclusion, anti-arrhythmics are a crucial category of pharmaceutical APIs used to treat various types of irregular heart rhythms. They are formulated into medications that help regulate the heart's electrical signals, reduce associated risks, and improve patient outcomes.

• Danashmand from India, product country of origin India
• Nobilus Ent from Poland, product country of origin Poland
• Vital Laboratories Pvt. Ltd. from India, product country of origin India
• Boehringer Ingelheim from Germany, product country of origin Unknown
• Alkaloids Corporation from India, product country of origin India

Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.

You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.